Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis

Patricia Murphy, Anthony Sharp, Joseph Shin, Vitaliy Gavrilyuk, Cinzia Dello Russo, Guy Weinberg, Frank R Sharp, Aigang Lu, Michael T. Heneka, Douglas L. Feinstein

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The production of nitric oxide by the inflammatory isoform of nitric oxide synthase (NOS2) in brain glial cells is thought to contribute to the causes and development of neurological diseases and trauma. We previously demonstrated that activation of a heat shock response (HSR) by hyperthermia reduced NOS2 expression in vitro, and in vivo attenuated the clinical and histological symptoms of the demyelinating disease experimental autoimmune encephalomyelitis (EAE; Heneka et al. [2001] J. Neurochem. 77:568-579). Benzoquinoid ansamycins are fungal-derived antibiotics with tyrosine kinase inhibitory properties, and which also induce a HSR by allowing activation of HS transcription factor HSF1. We now show that two members of this class of drugs (geldanamycin and 17-allylamino-17-demethoxygeldanamycin) also induce a HSR in primary rat astrocytes and rat C6 glioma cells. Both drugs dose-dependently reduced nitrite accumulation, NOS2 steady-state mRNA levels, and the cytokine-dependent activation of a rat 2.2-kB NOS2 promoter construct stably expressed in C6 cells. These inhibitory effects were partially reversed by quercetin, a bioflavonoid which prevents HSF1 binding to DNA and thus attenuates the HSR. Ansamycins increased mRNA levels of the inhibitory IκBα protein, suggesting that inhibition of NFκB activation could contribute to their suppressive effects. Finally, in C57BL/6 mice actively immunized to develop EAE, a single injection of geldanamycin at 3 days after immunization reduced disease onset by over 50%. These results indicate that ansamycins can exert potent anti-inflammatory effects on brain glial cells which may provide therapeutic benefit in neuroinflammatory diseases.

Original languageEnglish (US)
Pages (from-to)461-470
Number of pages10
JournalJournal of Neuroscience Research
Volume67
Issue number4
DOIs
StatePublished - Feb 15 2002
Externally publishedYes

Fingerprint

Macrocyclic Lactams
Heat-Shock Response
Autoimmune Experimental Encephalomyelitis
Nitric Oxide Synthase Type II
tanespimycin
Neuroglia
Messenger RNA
Quercetin
Brain
Demyelinating Diseases
Nitrites
Inbred C57BL Mouse
Flavonoids
Nitric Oxide Synthase
Glioma
Astrocytes
Pharmaceutical Preparations
Protein-Tyrosine Kinases
Immunization
Nitric Oxide

Keywords

  • Astrocytes
  • Cytokines
  • Heat shock response
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. / Murphy, Patricia; Sharp, Anthony; Shin, Joseph; Gavrilyuk, Vitaliy; Dello Russo, Cinzia; Weinberg, Guy; Sharp, Frank R; Lu, Aigang; Heneka, Michael T.; Feinstein, Douglas L.

In: Journal of Neuroscience Research, Vol. 67, No. 4, 15.02.2002, p. 461-470.

Research output: Contribution to journalArticle

Murphy, P, Sharp, A, Shin, J, Gavrilyuk, V, Dello Russo, C, Weinberg, G, Sharp, FR, Lu, A, Heneka, MT & Feinstein, DL 2002, 'Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis', Journal of Neuroscience Research, vol. 67, no. 4, pp. 461-470. https://doi.org/10.1002/jnr.10139
Murphy, Patricia ; Sharp, Anthony ; Shin, Joseph ; Gavrilyuk, Vitaliy ; Dello Russo, Cinzia ; Weinberg, Guy ; Sharp, Frank R ; Lu, Aigang ; Heneka, Michael T. ; Feinstein, Douglas L. / Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. In: Journal of Neuroscience Research. 2002 ; Vol. 67, No. 4. pp. 461-470.
@article{52d9feb9ec844115b4e6ac167ac56928,
title = "Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis",
abstract = "The production of nitric oxide by the inflammatory isoform of nitric oxide synthase (NOS2) in brain glial cells is thought to contribute to the causes and development of neurological diseases and trauma. We previously demonstrated that activation of a heat shock response (HSR) by hyperthermia reduced NOS2 expression in vitro, and in vivo attenuated the clinical and histological symptoms of the demyelinating disease experimental autoimmune encephalomyelitis (EAE; Heneka et al. [2001] J. Neurochem. 77:568-579). Benzoquinoid ansamycins are fungal-derived antibiotics with tyrosine kinase inhibitory properties, and which also induce a HSR by allowing activation of HS transcription factor HSF1. We now show that two members of this class of drugs (geldanamycin and 17-allylamino-17-demethoxygeldanamycin) also induce a HSR in primary rat astrocytes and rat C6 glioma cells. Both drugs dose-dependently reduced nitrite accumulation, NOS2 steady-state mRNA levels, and the cytokine-dependent activation of a rat 2.2-kB NOS2 promoter construct stably expressed in C6 cells. These inhibitory effects were partially reversed by quercetin, a bioflavonoid which prevents HSF1 binding to DNA and thus attenuates the HSR. Ansamycins increased mRNA levels of the inhibitory IκBα protein, suggesting that inhibition of NFκB activation could contribute to their suppressive effects. Finally, in C57BL/6 mice actively immunized to develop EAE, a single injection of geldanamycin at 3 days after immunization reduced disease onset by over 50{\%}. These results indicate that ansamycins can exert potent anti-inflammatory effects on brain glial cells which may provide therapeutic benefit in neuroinflammatory diseases.",
keywords = "Astrocytes, Cytokines, Heat shock response, Multiple sclerosis",
author = "Patricia Murphy and Anthony Sharp and Joseph Shin and Vitaliy Gavrilyuk and {Dello Russo}, Cinzia and Guy Weinberg and Sharp, {Frank R} and Aigang Lu and Heneka, {Michael T.} and Feinstein, {Douglas L.}",
year = "2002",
month = "2",
day = "15",
doi = "10.1002/jnr.10139",
language = "English (US)",
volume = "67",
pages = "461--470",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis

AU - Murphy, Patricia

AU - Sharp, Anthony

AU - Shin, Joseph

AU - Gavrilyuk, Vitaliy

AU - Dello Russo, Cinzia

AU - Weinberg, Guy

AU - Sharp, Frank R

AU - Lu, Aigang

AU - Heneka, Michael T.

AU - Feinstein, Douglas L.

PY - 2002/2/15

Y1 - 2002/2/15

N2 - The production of nitric oxide by the inflammatory isoform of nitric oxide synthase (NOS2) in brain glial cells is thought to contribute to the causes and development of neurological diseases and trauma. We previously demonstrated that activation of a heat shock response (HSR) by hyperthermia reduced NOS2 expression in vitro, and in vivo attenuated the clinical and histological symptoms of the demyelinating disease experimental autoimmune encephalomyelitis (EAE; Heneka et al. [2001] J. Neurochem. 77:568-579). Benzoquinoid ansamycins are fungal-derived antibiotics with tyrosine kinase inhibitory properties, and which also induce a HSR by allowing activation of HS transcription factor HSF1. We now show that two members of this class of drugs (geldanamycin and 17-allylamino-17-demethoxygeldanamycin) also induce a HSR in primary rat astrocytes and rat C6 glioma cells. Both drugs dose-dependently reduced nitrite accumulation, NOS2 steady-state mRNA levels, and the cytokine-dependent activation of a rat 2.2-kB NOS2 promoter construct stably expressed in C6 cells. These inhibitory effects were partially reversed by quercetin, a bioflavonoid which prevents HSF1 binding to DNA and thus attenuates the HSR. Ansamycins increased mRNA levels of the inhibitory IκBα protein, suggesting that inhibition of NFκB activation could contribute to their suppressive effects. Finally, in C57BL/6 mice actively immunized to develop EAE, a single injection of geldanamycin at 3 days after immunization reduced disease onset by over 50%. These results indicate that ansamycins can exert potent anti-inflammatory effects on brain glial cells which may provide therapeutic benefit in neuroinflammatory diseases.

AB - The production of nitric oxide by the inflammatory isoform of nitric oxide synthase (NOS2) in brain glial cells is thought to contribute to the causes and development of neurological diseases and trauma. We previously demonstrated that activation of a heat shock response (HSR) by hyperthermia reduced NOS2 expression in vitro, and in vivo attenuated the clinical and histological symptoms of the demyelinating disease experimental autoimmune encephalomyelitis (EAE; Heneka et al. [2001] J. Neurochem. 77:568-579). Benzoquinoid ansamycins are fungal-derived antibiotics with tyrosine kinase inhibitory properties, and which also induce a HSR by allowing activation of HS transcription factor HSF1. We now show that two members of this class of drugs (geldanamycin and 17-allylamino-17-demethoxygeldanamycin) also induce a HSR in primary rat astrocytes and rat C6 glioma cells. Both drugs dose-dependently reduced nitrite accumulation, NOS2 steady-state mRNA levels, and the cytokine-dependent activation of a rat 2.2-kB NOS2 promoter construct stably expressed in C6 cells. These inhibitory effects were partially reversed by quercetin, a bioflavonoid which prevents HSF1 binding to DNA and thus attenuates the HSR. Ansamycins increased mRNA levels of the inhibitory IκBα protein, suggesting that inhibition of NFκB activation could contribute to their suppressive effects. Finally, in C57BL/6 mice actively immunized to develop EAE, a single injection of geldanamycin at 3 days after immunization reduced disease onset by over 50%. These results indicate that ansamycins can exert potent anti-inflammatory effects on brain glial cells which may provide therapeutic benefit in neuroinflammatory diseases.

KW - Astrocytes

KW - Cytokines

KW - Heat shock response

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0037083197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037083197&partnerID=8YFLogxK

U2 - 10.1002/jnr.10139

DO - 10.1002/jnr.10139

M3 - Article

C2 - 11835313

AN - SCOPUS:0037083197

VL - 67

SP - 461

EP - 470

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 4

ER -